Canada reports second case of rare blood clot after AstraZeneca jab
Canada has recorded the second case of rare but serious blood clotting linked to AstraZeneca’s Covid-19 vaccine, authorities confirmed on Snday.
Canadian authorities still recommend people get the vaccine jab.
The patient, who lives in the western province of Alberta and received a version of the AstraZeneca vaccine supplied by the Serum Institute of India, “has received treatment and is recovering,” Canadian health authorities wrote on Twitter.
Canada reported its first case of blood clotting associated with low platelets on Tuesday in a Quebec woman who received the same shot.
Blood clot formations linked to the AstraZeneca vaccine “remain very rare” and Canada still believes that the vaccine’s benefits “outweigh the potential risks,” Health Canada and the Public Health Agency of Canada said.